225 related articles for article (PubMed ID: 35469784)
1. Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma.
Bai YP; Yang CJ; Deng N; Zhang M; Zhang ZJ; Li L; Zhou Y; Luo XF; Xu CR; Zhang BQ; Ma Y; Liu YQ
Biochem Pharmacol; 2022 Jun; 200():115049. PubMed ID: 35469784
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects and mechanism of a novel camptothecin derivative YCJ100.
Zhang M; Fu W; Zhu LZ; Liu XF; Li L; Peng LZ; Kai GY; Liu YQ; Zhang ZJ; Xu CR
Life Sci; 2022 Dec; 311(Pt A):121105. PubMed ID: 36272467
[TBL] [Abstract][Full Text] [Related]
3. Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I.
Zhang M; Zhu LZ; Yang CJ; Yan JX; Wang ZP; Bai YP; Peng LZ; Luo HB; Zhang ZJ; Li L; Xu CR; Liu YQ
Bioorg Chem; 2023 Oct; 139():106652. PubMed ID: 37390632
[TBL] [Abstract][Full Text] [Related]
4. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y
Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of Aza-boeravinone derivatives as potential novel topoisomerase I inhibitors.
Zhou Y; Bai YP; Zhang M; Gao JM; Yang CJ; Zhang ZJ; Deng N; Li L; Liu YQ; Xu CR
Bioorg Chem; 2022 May; 122():105747. PubMed ID: 35338969
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.
Yang CJ; Li B; Zhang ZJ; Gao JM; Wang MJ; Zhao XB; Song ZL; Liu YQ; Li H; Chen Y; Lee KH; Morris-Natschke SL; Xu C
Eur J Med Chem; 2020 Feb; 187():111971. PubMed ID: 31881457
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor.
Lee JH; Lee JM; Kim JK; Ahn SK; Lee SJ; Kim MY; Jew SS; Park JG; Hong CI
Arch Pharm Res; 1998 Oct; 21(5):581-90. PubMed ID: 9875499
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors.
Kurtzberg LS; Battle T; Rouleau C; Bagley RG; Agata N; Yao M; Schmid S; Roth S; Crawford J; Krumbholz R; Ewesuedo R; Yu XJ; Wang F; Lavoie EJ; Teicher BA
Mol Cancer Ther; 2008 Oct; 7(10):3212-22. PubMed ID: 18852125
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel 20(S)-α-aminophosphonate derivatives of camptothecin as potent antitumor agents.
Chen YY; Bai YP; Li B; Zhao XB; Yang CJ; Liu YQ; Gao JM; Guo J; Li C; Peng JW; Zhao ZM; Zhang ZJ; Xu CR
Bioorg Chem; 2021 Sep; 114():105065. PubMed ID: 34174631
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.
Zheng S; Chang S; Lu J; Chen Z; Xie L; Nie Y; He B; Zou S; Gu Z
PLoS One; 2011; 6(6):e21064. PubMed ID: 21695227
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of novel 20-O-linked homocamptothecin ester derivatives as potent topoisomerase I inhibitors.
Li DZ; Wang CY; Liu RH; Wang YM; Ji TF; Li YR; Pan XD
J Asian Nat Prod Res; 2013 Nov; 15(11):1179-88. PubMed ID: 24215541
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity.
Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ
ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of artemyrianolide H derivatives as potential antihepatoma agents.
Li TZ; Yang XT; Ma WJ; Ma YB; Li FJ; Wang YC; Chen JJ
Bioorg Chem; 2023 Aug; 137():106617. PubMed ID: 37267793
[TBL] [Abstract][Full Text] [Related]
18. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.
Zhao XB; Goto M; Song ZL; Morris-Natschke SL; Zhao Y; Wu D; Yang L; Li SG; Liu YQ; Zhu GX; Wu XB; Lee KH
Bioorg Med Chem Lett; 2014 Aug; 24(16):3850-3. PubMed ID: 25008456
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Structure-Activity Analysis of Icaritin Derivatives as Potential Tumor Growth Inhibitors of Hepatocellular Carcinoma Cells.
Li J; Shen S; Liu Z; Zhao H; Liu S; Liu Q; Yao GD; Song SJ
J Nat Prod; 2023 Feb; 86(2):290-306. PubMed ID: 36745506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]